Studies on experimental mouse mastitis relative to the assessment of pharmaceutical substances.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003091:Colistin / Q000627:therapeutic use; D003352:Corynebacterium / Q000472:pathogenicity; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000472:pathogenicity; D005260:Female; D008413:Mastitis / Q000188:drug therapy*; D051379:Mice; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011247:Pregnancy; D011550:Pseudomonas aeruginosa / Q000472:pathogenicity; D013210:Staphylococcus / Q000472:pathogenicity; D013291:Streptococcus / Q000472:pathogenicity
D000900:Anti-Bacterial Agents; D010406:Penicillins; D011113:Polymyxins; D003091:Colistin